CARBACHOL Drug Patent Profile
✉ Email this page to a colleague
When do Carbachol patents expire, and when can generic versions of Carbachol launch?
Carbachol is a drug marketed by Pharmafair and is included in one NDA.
The generic ingredient in CARBACHOL is carbachol. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the carbachol profile page.
Summary for CARBACHOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Clinical Trials: | 7 |
Patent Applications: | 3,342 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CARBACHOL at DailyMed |
Recent Clinical Trials for CARBACHOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Visus Therapeutics | Phase 3 |
Visus Therapeutics | Phase 2 |
Heidelberg University |
Medical Subject Heading (MeSH) Categories for CARBACHOL
Anatomical Therapeutic Chemical (ATC) Classes for CARBACHOL
US Patents and Regulatory Information for CARBACHOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmafair | CARBACHOL | carbachol | SOLUTION;INTRAOCULAR | 070292-001 | May 21, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |